Fagan Associates’s Bristol-Myers Squibb BMY Stock Holding History

Fagan Associates’s Portfolio BMY Stock Details BMY Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.58M	Buy	77,259 +24,737	+47%	+$1.15M	0.55%	51
2025 Q1	$3.2M	Buy	52,522 +46,295	+743%	+$2.82M	0.53%	56
2024 Q4	$352K	Buy	6,227 +500	+9%	+$28.3K	0.06%	109
2024 Q3	$296K	Buy	+5,727	New	+$296K	0.05%	114
2024 Q2	–	Sell	-4,727	Closed	-$256K	–	119
2024 Q1	$256K	Hold	4,727	–	–	0.05%	113
2023 Q4	$243K	Sell	4,727 -62	-1%	-$3.18K	0.05%	107
2023 Q3	$278K	Hold	4,789	–	–	0.07%	97
2023 Q2	$306K	Sell	4,789 -75	-2%	-$4.8K	0.07%	96
2023 Q1	$337K	Hold	4,864	–	–	0.08%	100
2022 Q4	$350K	Hold	4,864	–	–	0.09%	98
2022 Q3	$346K	Hold	4,864	–	–	0.1%	95
2022 Q2	$375K	Hold	4,864	–	–	0.1%	93
2022 Q1	$355K	Hold	4,864	–	–	0.07%	111
2021 Q4	$303K	Sell	4,864 -54,555	-92%	-$3.4M	0.06%	114
2021 Q3	$3.52M	Buy	59,419 +4,626	+8%	+$274K	0.76%	40
2021 Q2	$3.66M	Buy	54,793 +460	+0.8%	+$30.7K	0.78%	38
2021 Q1	$3.43M	Buy	54,333 +10,160	+23%	+$641K	0.8%	40
2020 Q4	$2.74M	Buy	44,173 +386	+0.9%	+$23.9K	0.69%	42
2020 Q3	$2.64M	Buy	43,787 +600	+1%	+$36.2K	0.76%	37
2020 Q2	$2.54M	Buy	43,187 +13,731	+47%	+$807K	0.81%	37
2020 Q1	$1.64M	Buy	29,456 +9,341	+46%	+$521K	0.65%	43
2019 Q4	$1.29M	Buy	20,115 +12,865	+177%	+$826K	0.42%	58
2019 Q3	$368K	Buy	+7,250	New	+$368K	0.14%	91
2019 Q2	–	Sell	-4,310	Closed	-$206K	–	113
2019 Q1	$206K	Sell	4,310 -80	-2%	-$3.82K	0.09%	110
2018 Q4	$228K	Buy	4,390 +455	+12%	+$23.6K	0.12%	99
2018 Q3	$244K	Sell	3,935 -450	-10%	-$27.9K	0.1%	109
2018 Q2	$243K	Sell	4,385 -2,685	-38%	-$149K	0.11%	104
2018 Q1	$447	Sell	7,070 -100	-1%	-$6	0.19%	83
2017 Q4	$439	Sell	7,170 -725	-9%	-$44	0.18%	88
2017 Q3	$503K	Hold	7,895	–	–	0.25%	80
2017 Q2	$440K	Sell	7,895 -350	-4%	-$19.5K	0.23%	82
2017 Q1	$448K	Buy	8,245 +50	+0.6%	+$2.72K	0.25%	77
2016 Q4	$479K	Buy	+8,195	New	+$479K	0.28%	79